Related Experiment Video
Updated: Jan 22, 2026

ATAC-Seq Optimization for Cancer Epigenetics Research
Published on: June 30, 2022
Epidrugs: targeting epigenetic marks in cancer treatment
Cristiana Libardi Miranda Furtado1, Maria Claudia Dos Santos Luciano2, Renan Da Silva Santos2
1Department of Surgery, Drug Research and Development Center, Federal University of Ceara , Fortaleza , Brazil.
Abstract:
Growing evidence suggests that aberrant epigenetic regulation of gene function is strongly related to the genesis of cancer. Unlike genetic mutations, the ability to reprogram the epigenetic landscape in the cancer epigenome is one of the most promising target therapies in both treatment and reversibility of drug resistance. Epigenetic alterations in cancer development and progression may be the basis for the individual variation in drug response. Thus, this review focuses on the emerging area of pharmaco(epi)genomics, specifically highlighting epigenetic reprogramming during tumorigenesis and how epigenetic markers are targeted as a therapy (epidrugs) and the clinical implications of this for cancer treatment.
Insights
Aberrant epigenetic regulation drives cancer genesis. Reprogramming the cancer epigenome offers promising therapeutic strategies and reversibility for drug resistance, impacting personalized cancer treatment.
Area of Science:
- Oncology
- Epigenetics
- Pharmacogenomics
Background:
- Aberrant epigenetic regulation is linked to cancer development.
- Epigenetic alterations influence individual drug responses in cancer patients.
- The reversibility of epigenetic changes presents therapeutic opportunities.
Purpose of the Study:
- To review the role of epigenetic reprogramming in tumorigenesis.
- To highlight the targeting of epigenetic markers as cancer therapy (epidrugs).
- To discuss the clinical implications of pharmaco(epi)genomics in cancer treatment.
Main Methods:
- Literature review of epigenetic reprogramming in cancer.
- Analysis of epidrugs targeting epigenetic markers.
- Discussion of clinical applications and challenges.
Main Results:
- Epigenetic reprogramming is a key factor in cancer development.
- Epidrugs show potential for cancer treatment and overcoming drug resistance.
- Pharmaco(epi)genomics offers personalized treatment strategies.
Conclusions:
- Targeting epigenetic modifications is a promising avenue for cancer therapy.
- Understanding epigenetic alterations can improve drug efficacy and reduce resistance.
- Pharmaco(epi)genomics holds significant potential for precision oncology.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bone Markings
Articulating Projections
Articulating projections are found where two bones meet to form a joint. These structures are usually found at the ends of bones. The largest articulation is a rounded projection called the head, supported by a narrow neck at the ends of...
Design Example: Marking Boundaries of a Site Using a Compass

